Zachary Shriver
Directeur Technique/Scientifique/R&D chez VISTERRA INC
Profil
Zachary H.
Shriver is currently the Chief Scientific Officer at Visterra, Inc. Previously, he worked as the Senior Director-Research Analytics at Momenta Pharmaceuticals, Inc. He completed his undergraduate degree at Amherst College and holds a doctorate from the Massachusetts Institute of Technology.
Postes actifs de Zachary Shriver
| Sociétés | Poste | Début |
|---|---|---|
| VISTERRA INC | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Zachary Shriver
| Sociétés | Poste | Fin |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Zachary Shriver
| Massachusetts Institute of Technology | Doctorate Degree |
| Amherst College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |